Author name: DrugPatentWatch

The African pharmaceutical sector stands at a definitive crossroads in the mid-2020s, characterized by a bifurcation of strategy between its […]

Introduction: Two Classes of Drugs, Two Worlds of Protection In biopharmaceutical innovation not all molecules are created equal. On one

I. Introduction: The Billion-Dollar Labyrinth The High-Stakes World of Biologic Patents A patent is far more than a legal instrument;

A new and disruptive force has emerged American pharmaceutical industry, operating at the dynamic intersection of manufacturing, pharmacy practice, and

Executive Summary: The Financial Physics of Exclusivity The pharmaceutical industry approaches a defining economic event: the scheduled expiration of intellectual

Introduction: The Billion-Dollar Clock In biopharmaceutical innovation time is the most valuable and fiercely contested asset. For an innovator company,

I. Introduction: The End of an Era and the Dawn of a New Value Equation For decades, the pharmaceutical industry

1. Executive Strategic Overview: The Fallacy of the Patent Cliff In the pharmaceutical industry, the “patent cliff” is often discussed

Welcome. If you’re reading this, you likely live and breathe the central paradox of our industry. On one hand, the